Phosphatidylinositol inhibits respiratory syncytial virus infection

Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection

(2013) Mari Numata et al.   JOURNAL OF LIPID RESEARCH

Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication

(2012) Nico Marr et al.   Innate Immunity

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Anionic pulmonary surfactant lipid regulation of innate immunity

(2012) Mari Numata et al.   Expert Review of Respiratory Medicine

Phosphatidylglycerol Suppresses Influenza A Virus Infection

(2011) Mari Numata et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Pulmonary Surfactant Phosphatidylglycerol InhibitsMycoplasma pneumoniae-stimulated Eicosanoid Production from Human and Mouse Macrophages

(2011) Pitchaimani Kandasamy et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Identification of nucleolin as a cellular receptor for human respiratory syncytial virus

(2011) Farnoosh Tayyari et al.   NATURE MEDICINE

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

(2010) Harish Nair et al.   LANCET

Anionic Pulmonary Surfactant Phospholipids Inhibit Inflammatory Responses from Alveolar Macrophages and U937 Cells by Binding the Lipopolysaccharide-interacting Proteins CD14 and MD-2

(2009) Koji Kuronuma et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection

(2009) M. Numata et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA